Marth C - Search Results

1

The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.

Hofstetter G, Berger A, Berger R, Zorić A, Braicu EI, Reimer D, Fiegl H, Marth C, Zeimet AG, Ulmer H, Moll U, Zeillinger R, Concin N. Hofstetter G, et al. Among authors: marth c. Int J Gynecol Cancer. 2012 Mar;22(3):372-9. doi: 10.1097/IGC.0b013e31823ca031. Int J Gynecol Cancer. 2012. PMID: 22246403

2

[Prognostic significance of tumor markers in cervix cancer].

Marth C, Zeimet AG, Fuith LC, Hetzel H, Zech S, Daxenbichler G. Marth C, et al. Gynakol Geburtshilfliche Rundsch. 1992;32 Suppl 1:114. doi: 10.1159/000271963. Gynakol Geburtshilfliche Rundsch. 1992. PMID: 1286307 Free article. German. No abstract available.

3

[The value of tumor markers in vulvar cancer].

Zeimet AG, Marth C, Abfalter E, Müller-Holzner E, Heim K, Pinzger G, Baumgartner P, Daxenbichler G, Dapunt O. Zeimet AG, et al. Among authors: marth c. Gynakol Geburtshilfliche Rundsch. 1992;32 Suppl 1:28-30. doi: 10.1159/000271927. Gynakol Geburtshilfliche Rundsch. 1992. PMID: 1286338 German. No abstract available.

4

[Magnetic resonance tomography in follow-up of hydatidiform mole].

Marth C, Judmaier W, Helweg G, Schwegel P, Wicke K, Zeimet AG, Daxenbichler G, Hetzel H. Marth C, et al. Geburtshilfe Frauenheilkd. 1992 Aug;52(8):501-3. doi: 10.1055/s-2007-1023799. Geburtshilfe Frauenheilkd. 1992. PMID: 1327942 German.

5

[Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells].

Marth C, Müller-Holzner E, Zeimet AG, Greiter E, Cronauer MV, Doppler W, Eibl B, Hynes NE, Daxenbichler G. Marth C, et al. Gynakol Geburtshilfliche Rundsch. 1992;32(1):31-4. doi: 10.1159/000271830. Gynakol Geburtshilfliche Rundsch. 1992. PMID: 1355379 German.

6

Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells.

Marth C, Lang T, Cronauer MV, Doppler W, Zeimet AG, Bachmair F, Ullrich A, Daxenbichler G. Marth C, et al. Int J Cancer. 1992 Sep 9;52(2):311-6. doi: 10.1002/ijc.2910520226. Int J Cancer. 1992. PMID: 1355758

7

Modulation of tumour marker CA-125 expression in cultured ovarian carcinoma cells.

Marth C, Zeimet AG, Böck G, Daxenbichler G. Marth C, et al. Eur J Cancer. 1992;28A(12):2002-6. doi: 10.1016/0959-8049(92)90248-z. Eur J Cancer. 1992. PMID: 1419298

8

Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.

Marth C, Müller-Holzner E, Greiter E, Cronauer MV, Zeimet AG, Doppler W, Eibl B, Hynes NE, Daxenbichler G. Marth C, et al. Cancer Res. 1990 Nov 1;50(21):7037-41. Cancer Res. 1990. PMID: 2119884

9

Distribution of CA 125 in placental tissues.

Fuith LC, Müller-Holzner E, Marth C, Perkmann E, Zeimet A, Daxenbichler G. Fuith LC, et al. Among authors: marth c. Int J Biol Markers. 1989 Apr-Jun;4(2):78-80. doi: 10.1177/172460088900400203. Int J Biol Markers. 1989. PMID: 2768891

10

Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patients.

Marth C, Weiss G, Koza A, Reibnegger G, Daxenbichler G, Zeimet AG, Fuchs D, Wachter H, Dapunt O. Marth C, et al. Int J Cancer. 1994 Jul 1;58(1):20-3. doi: 10.1002/ijc.2910580105. Int J Cancer. 1994. PMID: 7516925 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

478 results

Search Page